Biolytx pharmaceuticals corp
WebBiolytx Pharmaceuticals. Biolytx is an emerging drug development company confronting the crisis in antibiotic (AB) drug resistance through the advancement of a suite of … Dr. Pereira is the holder of 15 US patents and 4 foreign patents licensed to Biolytx. … The CSO of Biolytx characterized, sequenced, and cloned the peptide and … BP001. BP001 is an antibiotic and wound healing agent for infected eye wounds. … Pre-Clinical Stage. All of our drug candidates are in the pre-clinical stage … INVESTORS We completed a $1.5 million seed round of financing in 2015, led by … Biolytx Pharmaceuticals Targets Drug-Resistant Bacteria March 25 , 2015 – … Biolytx Pharmaceuticals Corporation 800 Research Parkway, Suite Oklahoma … William A Hagstrom Board Member and Co-Founder. Mr. Hagstrom has served as a … WebBiolytx Pharmaceuticals Corp. is developing a peptide, BP001, derived from the human endogenous host defense protein CAP37, as a novel multi-target ophthalmic product for corneal infections and injuries. The standard-of-care for corneal infections is topical administration of antibiotics that may be accompanied by topical
Biolytx pharmaceuticals corp
Did you know?
WebBiolytx Pharmaceuticals Corp. is developing a peptide, BP001, derived from the human endogenous host defense protein CAP37, as a novel multi-target ophthalmic product for … WebBiolytx Pharmaceuticals is a pharmaceutical technology company developed by Dr. Anne Pereira and the University of Oklahoma Health Sciences Center. Still in the pre-clinical …
WebNov 7, 2015 · Biolytx funds raised Biolytx is developing a drug designed to promote wound healing and kill antibiotic resistant bacteria. This latest financing also included $200,000 from i2E-managed SeedStep Angels group, $250,000 from an Oklahoma venture capital fund and $150,000 in investment by Biolytx management.
WebCompany profile page for Biolytx Pharmaceuticals Corp including stock price, company news, press releases, executives, board members, and contact information Skip To … WebWilliam A. Hagstrom. Mr. Hagstrom has served as a member of our Board of Directors since incorporation in 2005. He has served as the founder and CEO of Octave Bioscience, an early-stage diagnostics company focused on neurodegenerative diseases since 2014.
WebOct 16, 2015 · Biolytx Pharmaceuticals General Information Description Developer of peptide-based antibiotics designed to treat serious pathogens with no current therapeutic …
WebOct 16, 2015 · Biolytx Pharmaceuticals General Information. Description. Developer of peptide-based antibiotics designed to treat serious pathogens with no current therapeutic options. The company's antibiotics include a suite of antimicrobial drug candidates for the treatment of serious pathogens including those resistant to current antibiotics, enabling ... pool companies in fayetteville ncWebWilliam A. Hagstrom is an entrepreneur and businessperson who founded Biolytx Pharmaceuticals Corp., Crescendo Bioscience, Inc., Altheus Therapeutics, Inc. and Octave Bioscience, Inc. and who has been... sharath chandra chatterjeeWebBiolytx Pharmaceuticals Corp. Jan 2016 - May 2024 3 years 5 months. Oklahoma City, Oklahoma Vice President and General Counsel Amicus Therapeutics ... sharath chandra arrojuWebNov 9, 2015 · Biolytx Pharmaceuticals Corp., which is developing a drug designed to promote wound healing and kill antibiotic resistant bacteria, has raised a $1.1 million financing round led by i2E Inc ... sharath chandra mahavadiWebBiolytx Pharmaceuticals is a pharmaceutical technology company developed by Dr. Anne Pereira and the University of Oklahoma Health Sciences Center. Still in the pre-clinical trial stage, the company's core technology is the development of a novel antibiotic peptide for use in treatment of serious hospital-acquired infections, including those ... pool companies in daytona beachWebJul 29, 2024 · Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis – Drugs In Development, 2024, provides an overview of the Cystic Fibrosis (Respiratory) pipeline landscape. Cystic fibrosis (CF) is an inherited disease that causes mucus to build up and clog some of the body’s organs, particularly the lungs … pool companies in clarksville tnWebOKLAHOMA CITY, OK — A $500,000 investment from the i2E, Inc.-managed Oklahoma Seed Capital Fund recently led a $1.1 million financing round in Oklahoma City-based … pool companies in fredericksburg va